Tag Archives: GlaxoSmithKline

GSK Goes DTC for London Olympics

It’s an unusual sight in the UK — a television commercial for a Big Pharma company. But among the cultural and commercial innovations being attributed to the London Olympic Games is GSK’s first UK consumer-facing corporate brand campaign, showcasing its anti-doping operations. The TV ad debuted on July 16; this week, the company’s campaign went […]
Posted in Advertising, Europe, Global | Also tagged , , , , | 2 Comments

Comply or Die: Introducing GSK's New Corporate Integrity Agreement

Big pharma talks a lot about the changing business model and placing a new emphasis on patients, but the fact remains that quantity of medicines sold, not quality of care provided, is how to get paid (and how to keep investors happy). Despite its egalitarian trappings, the healthcare “ecosystem” is still dominated by the most […]
Posted in Agency Insight, compliance, Corporate Responsibility, Legal, Marketing, Regulatory, Sales, Strategy | Also tagged , , , , , , , , , | Leave a comment

GSK: A Rebuffed Suitor for the Moment

By Patricia Van Arnum. Last week Human Genome Sciences (HGS) rejected GlaxoSmithKline’s (GSK) unsolicited $2.59 billion bid for HGS or $13 per share.  Although rejecting GSK’s initial bid, HGS kept the door open for other suitors, including again GSK. HGS has authorized its board of directors to explore strategic alternatives for the company, including a […]
Posted in Deals, Guest Blog | Also tagged , , , | 1 Comment

Witty Touts GSK Pipeline in 4th Quarter Review

Posted in Emerging Markets, Europe, Global, News, R&D, Strategy | Also tagged , , , , , | Leave a comment

European Pharma 1981-2011: Survival of the Fittest?

This month sees Pharmaceutical Executive magazine reach its 30th birthday. In line with that milestone, Reflector assesses what the last three decades have meant for European pharma — and shows how the game has changed beyond recognition. Thirty years is a long time in any industry. The coalmining industry, the market for air travel, or […]
Posted in Emerging Markets, Europe, Global, Guest Blog, healthcare, IP, leadership, Pharm Exec Magazine, R&D, Regulatory | Also tagged , , , , , | Leave a comment
  • Categories

  • Meta